NASDAQ: MLAB
Mesa Laboratories Inc Stock

$67.40-1.39 (-2.02%)
Updated Aug 28, 2025
MLAB Price
$67.40
Fair Value Price
N/A
Market Cap
$370.80M
52 Week Low
$55.45
52 Week High
$155.12
P/E
-561.67x
P/B
2.15x
P/S
2.13x
PEG
N/A
Dividend Yield
0.95%
Revenue
$242.35M
Earnings
-$620.00k
Gross Margin
62.1%
Operating Margin
8.11%
Profit Margin
-0.3%
Debt to Equity
1.53
Operating Cash Flow
$38M
Beta
1.06
Next Earnings
N/A
Ex-Dividend
Aug 29, 2025
Next Dividend
Sep 15, 2025

MLAB Overview

Mesa Laboratories, Inc. develops, manufactures, and sells life sciences tools and quality control products and services in the United States, Europe, the Asia Pacific, and internationally. The company's Sterilization and Disinfection Control segment manufactures and sells biological, cleaning, and chemical indicators that are used to assess the effectiveness of sterilization and disinfection processes in the hospital, dental, medical device, and pharmaceutical industries. This segment also provides testing and laboratory services primarily to the dental industry. Its Biopharmaceutical Development segment develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. This segment's solutions include protein analysis comprising analysis equipment, CDs, kits, and buffers; and peptide synthesizers that enables to automate chemically synthesized peptides that are used in the creation of peptide therapies, biomaterials, cosmetics, and general research. The company's Calibration Solutions segment designs, manufactures, and markets quality control and calibration products to measure or calibrate temperature, pressure, pH, humidity, and other such parameters used for health and safety purposes in the hospital, medical device manufacturing, pharmaceutical manufacturing, and various laboratory and healthcare environments. This segment's products include continuous monitoring systems, dialysate meters and consumables, data loggers, gas flow calibration and air sampling equipment, and torque testing systems. Its Clinical Genomics segment develops, manufactures, and sells genetic analysis tools that include MassARRAY system and consumables, including chips, panels, and chemical reagent solutions used by clinical labs to perform genomic clinical testing in several therapeutic areas, such as newborn screenings, pharmacogenetics, and oncology. The company was incorporated in 1982 and is headquartered in Lakewood, Colorado.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine MLAB's potential to beat the market

CHold
  • Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More

Zen Rating Component Grades

D
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Scientific & Technical Instrument

Industry Rating
B
MLAB
Ranked
#9 of 24

Top Ranked Stocks in Industry

Name / TickerPriceZen Rating
$43.43A
$107.52A
$166.53B
View Top Scientific & Technical Instrument Stocks

Be the first to know about important MLAB news, forecast changes, insider trades & much more!

MLAB News

Overview

Due Diligence Score

Industry Average (30)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how MLAB scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

MLAB is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
MLAB is good value based on its book value relative to its share price (2.15x), compared to the US Scientific & Technical Instruments industry average (3.29x)
P/B vs Industry Valuation
MLAB is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 35 more MLAB due diligence checks available for Premium users.

Valuation

MLAB fair value

Fair Value of MLAB stock based on Discounted Cash Flow (DCF)

Price
$67.40
Fair Value
$268.18
Undervalued by
74.87%
MLAB is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

MLAB price to earnings (PE)

For valuing profitable companies with steady earnings

Company
-561.67x
Industry
18.32x
Market
35.78x

MLAB price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
2.15x
Industry
3.29x
MLAB is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

MLAB's financial health

Profit margin

Revenue
$59.5M
Net Income
$4.7M
Profit Margin
8%
MLAB's Earnings (EBIT) of $19.65M... subscribe to Premium to read more.
Interest Coverage Financials
MLAB's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$435.7M
Liabilities
$263.2M
Debt to equity
1.53
MLAB's short-term liabilities ($149.49M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
MLAB's long-term liabilities ($113.75M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
MLAB's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
MLAB's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$1.9M
Investing
-$1.0M
Financing
-$8.4M
MLAB's operating cash flow ($38.27M)... subscribe to Premium to read more.
Debt Coverage Financials

MLAB vs Scientific & Technical Instrument Stocks

TickerZen RatingMarket Cap1d %P/EP/B
MLABC$370.80M-2.01%-561.67x2.15x
VPGB$381.91M-1.74%-319.56x1.15x
MVISD$289.14M+3.57%-2.64x5.43x
BKSYF$572.28M-0.44%-8.29x6.44x
GNSSC$93.02M+7.57%-3.27x29.45x

Mesa Laboratories Stock FAQ

What is Mesa Laboratories's quote symbol?

(NASDAQ: MLAB) Mesa Laboratories trades on the NASDAQ under the ticker symbol MLAB. Mesa Laboratories stock quotes can also be displayed as NASDAQ: MLAB.

If you're new to stock investing, here's how to buy Mesa Laboratories stock.

What is the 52 week high and low for Mesa Laboratories (NASDAQ: MLAB)?

(NASDAQ: MLAB) Mesa Laboratories's 52-week high was $155.12, and its 52-week low was $55.45. It is currently -56.55% from its 52-week high and 21.55% from its 52-week low.

How much is Mesa Laboratories stock worth today?

(NASDAQ: MLAB) Mesa Laboratories currently has 5,501,454 outstanding shares. With Mesa Laboratories stock trading at $67.40 per share, the total value of Mesa Laboratories stock (market capitalization) is $370.80M.

Mesa Laboratories stock was originally listed at a price of $6.75 in Dec 31, 1997. If you had invested in Mesa Laboratories stock at $6.75, your return over the last 27 years would have been 898.52%, for an annualized return of 8.9% (not including any dividends or dividend reinvestments).

How much is Mesa Laboratories's stock price per share?

(NASDAQ: MLAB) Mesa Laboratories stock price per share is $67.40 today (as of Aug 28, 2025).

What is Mesa Laboratories's Market Cap?

(NASDAQ: MLAB) Mesa Laboratories's market cap is $370.80M, as of Aug 29, 2025.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Mesa Laboratories's market cap is calculated by multiplying MLAB's current stock price of $67.40 by MLAB's total outstanding shares of 5,501,454.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.